The largest database of trusted experimental protocols

4 protocols using ag019 1

1

Western Blot Analysis of CUGBP1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Heart tissues were homogenized and lysed in RIPA lysis buffer (Beyotime Bio Co, China). Proteins were separated by 12% SDS/PAGE, transferred to PVDF membranes (Millipore, USA), blocked and incubated with antibodies. Final detection was performed using enhanced chemiluminescence detection solutions 1 and 2 (1:1) (ECL; Millipore). The relative protein expression level was analyzed by densitometry using ImageJ software (Bethesda, Maryland, USA). Primary antibodies used in this study were as follows: anti-CUGBP1 (sc-20003, Santa Cruz Biotechnology, USA), anti-Xpress (R910-25, Thermo, USA), β-actin (AA128-1, Beyotime, China) or GAPDH (AG019-1, Beyotime, China) were detected as control.
+ Open protocol
+ Expand
2

Protein Extraction and Antibody Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lysates were prepared by extracting proteins with RIPA buffer. The membranes were blocked in 5% non-fat dried milk and incubated overnight at 4°C with the appropriate primary antibodies. The rabbit anti-human VASH2 monoclonal antibody utilized in the western blot analyses was kindly provided by Professor Sato. The antibodies against GAPDH (AG019-1, Beyotime, China), Vimentin (ab8069, Abcam, UK), E-cadherin (ab1416, Abcam), ZEB1 (ab124512, Abcam), ZEB2 (ab25837, Abcam), ABCC1 (ab84320, Abcam), MMP2 (ab86607, Abcam), Bcl-2 (#2870, Cell Signaling Technology, USA) and CXCR4 (ab2074, Abcam) are commercially available.
+ Open protocol
+ Expand
3

Western Blotting of EMT and Stemness Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed using standard protocols. Briefly, cells were sonicated in RIPA buffer, and 30 μg proteins was resolved on 12% polyacrylamide SDS gels and transferred to polyvinylidene difluoride (PVDF) membranes. The membranes were blocked with 5% BSA (bovine serum albumin) in TBS (tris‐buffered saline), incubated overnight at 4°C with the appropriate primary antibodies. The antibodies used included those against VASH2 (ab116640, Abcam, Cambridge, UK), GAPDH (AG019‐1, Beyotime, Shanghai, China), Vimentin (ab8069, Abcam), E‐cadherin (ab11512, Abcam), ZEB1 (ab124512, Abcam), ZEB2 (ab25837, Abcam), Bcl‐2 (ab32124, Abcam), SMO (ab38686,, Abcam), Gli‐1 (ab49314, Abcam), and Gli‐2 (ab167389, Abcam).
+ Open protocol
+ Expand
4

Protein extraction and Western blotting protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were extracted from cells or liver tissues in the lysis buffer (Beyotime, Shanghai, China) consisting of protease inhibitor cocktail (1:100, TargetMol, MA, USA). The concentration of proteins was determined using BCA Protein Assay kit (Beyotime). The extracted proteins were separated by 10% SDS/PAGE and electro‐transferred to PVDF membranes (Millipore, Billerica, MA, USA). After blocking in 5% milk for 1 h, the membranes were probed with primary antibodies against SLC27A5 (1:1000, NBP2‐37412, Novus Biologicals, CO, USA), α‐SMA (1:1000, ER1003, Huabio, Hangzhou, China), COL1A1 (1:1000, WL0088, Wanleibio, Shenyang, China), COL3A1 (1:1000, 22734‐1‐AP, Proteintech, IL, USA), RUNX2 (1:1000, 20700‐1‐AP, Proteintech, IL, USA), EGR3 (1:500, sc‐390967, Santa Cruz Biotechnology, USA), β‐actin (1:3000, BL005B, Biosharp), or GAPDH (1:3000, AG019‐1, Beyotime, Shanghai, China) at 4 °C overnight. Membranes were then incubated with horseradish peroxidase‐conjugated secondary antibody (Abcam, Cambridge, UK). The staining was visualized using ClarityTM Western ECL Substrate (Bio‐Rad, CA, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!